Introduction<br />In recent years, there has been a revolution in the field of biotechnology, with CRISPR-Cas9 emerging as one of the most important gene-editing tools. This technique, derived from a natural defense system in bacteria, has become a precise and effective method for modifying DNA, making it a focal point for scientists aiming to treat many genetic diseases.<br />What is CRISPR-Cas9?<br />CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) are sequences found in bacterial DNA that are used to recognize invading viruses. Cas9 is a "genetic scissors" protein that cuts DNA at a specific location. When directed to a particular gene, this system can remove, replace, or modify it, offering immense opportunities to treat genetic mutations.<br />How Does CRISPR Contribute to Correcting Genetic Mutations?<br />CRISPR is used to precisely identify disease-causing mutations and then make modifications by:<br />Cutting the defective gene and replacing it with a healthy one.<br />Disabling the disease-causing gene to reduce its impact or eliminate it entirely.<br />Repairing the incorrect gene sequence by introducing a correct version of the genetic code.<br />This approach has been tested on diseases such as:<br />Sickle Cell Anemia<br />Thalassemia<br />Genetic Muscular Dystrophy<br />Genetic Eye Diseases, like Hereditary Blindness<br />Promising Achievements<br />In 2020, the first clinical trials using CRISPR to treat sickle cell anemia showed positive results without serious complications. Additionally, cases of partial vision restoration for patients with hereditary blindness using this technique were reported, marking a true breakthrough in the future of genetic medicine.<br />Ethical and Scientific Challenges<br />Despite its immense potential, CRISPR raises important ethical issues, especially when used on human embryos or for non-medical purposes such as "enhancing genetic traits." Moreover, the possibility of off-target effects, where unintended parts of the DNA are modified, still poses a risk that requires continuous monitoring and development.<br />Conclusion<br />CRISPR-Cas9 represents a significant breakthrough in the treatment of genetic diseases, opening the door to precise, personalized treatments that were once considered impossible. As research and clinical trials continue to expand, there is genuine hope for treating genetic diseases that were once deemed incurable. However, it remains crucial to balance scientific progress with ethical safeguards to ensure the safe and responsible use of this revolutionary technology.<br />Huda Rafid Abd Alkhaliq<br />AL_mustaqbal University is the first university in Iraq